Julien Dall

Local Study Associate Director at Astrazeneca (Via Excelya) @AstraZeneca

Issy-les-Moulineaux, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Dec 2021 — Present

Local Study Associate Director at Astrazeneca (Via Excelya) @AstraZeneca

View department →

Courbevoie, FR

EDUCATION

2005 — 2007

Université Paris 5

Master, Physiopathologie cardiovasculaire et de l'hémostase humaine

2007 — 2011

Université Paris 7

Doctorat, Biologie et pharmacologie de l'hémostase et des vaisseaux

2002 — 2005

Université Paris 5

Licence, Biologie

2011 — 2012

Supsanté

Formation d'attaché de recherche clinique, Industrie pharmaceutique et recherche clinique

ABOUT JULIEN DALL

Over 5 years of experience working in the academic research sector as internship/PhD student/engineer in biomedical research Over 10 years of experience working in clinical research sector as clinical research associate/clinical trial project manager Experience in clinical research therapeutic areas and relevant phases of studies include- Clinical studies early & late stage: phase I, II, and IV - Observational studies - Medical device - ATU (temporary authorization for use)- HAS studies Therapeutic areas: Oncology, Cardiology, Hematology, Neurology, Diabetology, Ophthalmology, Pediatrics, Gastroenterology, Emergency & Pain (antalgic) Main responsibilities- studies management within quality, timelines, and budgets requirements - coordination of the different steps of the studies from preparation to results - Participate in regulatory submission to relevant authorities - Run a cross functional project team - Report to global study manager project progress, identify potential risks and mitigate risks Publications: Early Atheroma-Derived Agonists of Peroxisome Proliferator-Activated Receptor-{gamma} Trigger Intramedial Angiogenesis in a Smooth Muscle Cell-Dependent Manner. Le Dall J, Ho-Tin-Noé B, Gomez D, Louedec L, Vranckx R, El-Bouchtaoui M, Legrès L, Meilhac O, Michel JB. Circ Res. 2011 Oct 14;109(9):1003-14. Epub 2011 Sep 1. Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors. Le Dall J, Ho-Tin-Noé B, Louedec L, Meilhac O, Roncal C, Carmeliet P, Germain S, Michel JB, Houard X. Cardiovasc Res. 2010 Jan 1;85(1):184-93. Epub. Absence of inflammatory conditions in human varicose saphenous veins. Gomez I, Benyahia C, Le Dall J, Payré C, Louedec L, Leséche G, Lambeau G, Longrois D, Norel X. Inflamm Res. 2013 Mar;62(3):299-308.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Julien Dall — Local Study Associate Director at Astrazeneca (Via Excelya) at AstraZeneca in Issy-les-Moulineaux, FR | Unifers